Baxter International Stock Forecast for 2023 - 2025 - 2030

Updated on 02/04/2023

Stock Rating
17
Price Target
$58.00
Consensus
Outperform
Upside
24.25%
Analysts
6
Stock Rating
17
Upside
24.25%
Analysts
6
Price Target
$58.00

Baxter International Stock Forecast and Price Target

Baxter International's most recent price target of $58.00 for 2023 was provided by six renowned analysts over the past few months, with an average prediction of $58.00. If this prediction is correct, Baxter International's stock could rise by 24.25 percent from its current trading price. The potential increase for the stock is $58.00 per share, with a possible range of $51.00 to $85.00. If you're thinking of investing in BAX stock, it might be good to look at its rivals too.

$58.00

24.25% Upside

Outperform
Outperform

Baxter International Fair Value Forecast for 2023 - 2025 - 2030

In the last two years, Baxter International's Price has grown from $77.92 to $84.98 – a 9.06% increase. Next year, analysts are expecting Fair Value to reach $114.64 – an increase of 34.90%. Over the next eight years, the forecast is for Fair Value to grow by 69.86%.

2023 Fair Value Forecast
$114.64
2024 Fair Value Forecast
$129.47
2025 Fair Value Forecast
$142.65
2026 Fair Value Forecast
$154.66
2027 Fair Value Forecast
$139.99
2028 Fair Value Forecast
$136.95
2029 Fair Value Forecast
$139.20
2030 Fair Value Forecast
$144.34
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
JNJ Stock Forecast Johnson & Johnson Outperform 11
$164.61 $181.05 9.65%
LLY Stock Forecast Eli Lilly and Outperform 16
$339.08 $333.19 17.97%
PFE Stock Forecast Pfizer Inc Outperform 3
$44.06 $53.97 19.50%
AZN Stock Forecast AstraZeneca PLC Outperform 8
£10.58k £153.20 -98.53%
NOVN Stock Forecast Novartis Hold 10
CHF85.77 CHF103.75 9.89%

Baxter International Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Baxter International's Revenue has grown from $11.36B to $12.78B – a 12.52% increase. Next year, analysts are expecting Revenue to reach $16.65B – an increase of 30.23%. Over the next eight years, the forecast is for Revenue to grow by 45.11%.

2023 Rev Forecast
$16.65B
2024 Rev Forecast
$17.41B
2025 Rev Forecast
$18.32B
2026 Rev Forecast
$19.31B
2027 Rev Forecast
$18.38B
2028 Rev Forecast
$18.07B
2029 Rev Forecast
$18.17B
2030 Rev Forecast
$18.55B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ABT Stock Forecast Abbott Laboratories Outperform 10
$111.79 $120.97 11.82%
BMY Stock Forecast Bristol-Myers Squibb Co Outperform 2
$74.45 $80.99 11.48%
CSL Stock Forecast CSL Outperform 8
$313.81 $218.60 -27.96%

Baxter International Dividend per Share Forecast for 2023 - 2025 - 2030

In the last two years, Baxter International's Dividend per Share has grown by 28.24%, rising from $0.85 to $1.09. For next year, analysts predict Dividend per Share of $1.31, which would mean an increase of 20.18%. Over the next eight years, experts predict that Baxter International's Dividend per Share will grow at a rate of 59.42%.

2023 DPS Forecast
$1.31
2024 DPS Forecast
$1.39
2025 DPS Forecast
$1.72
2026 DPS Forecast
$1.92
2027 DPS Forecast
$1.69
2028 DPS Forecast
$1.60
2029 DPS Forecast
$1.65
2030 DPS Forecast
$1.74
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ISRG Stock Forecast Intuitive Surgical Inc Outperform 15
$254.68 $273.80 10.73%
GE Stock Forecast General Electric Outperform 9
$81.96 $86.47 6.15%
BDX Stock Forecast Becton, Dickinson and Outperform 17
$245.84 $268.00 11.86%

Baxter International Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last two years, Baxter International's Free Cash Flow has grown, rising from $1.41B to $1.48B – a growth of 5.04%. In the next year, analysts believe that Free Cash Flow will reach $2.10B – an increase of 41.92%. For the next eight years, the forecast is for Free Cash Flow to grow by 108.43%.

2023 FCF Forecast
$2.10B
2024 FCF Forecast
$2.55B
2025 FCF Forecast
$3.34B
2026 FCF Forecast
$3.29B
2027 FCF Forecast
$2.85B
2028 FCF Forecast
$2.79B
2029 FCF Forecast
$2.97B
2030 FCF Forecast
$3.08B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
MMM Stock Forecast 3M Hold 16
$117.49 $147.79 1.71%
BSX Stock Forecast Boston Scientific Outperform 15
$48.50 $50.77 3.09%
EW Stock Forecast Edwards Lifesciences Outperform 15
$82.12 $92.45 13.25%

Baxter International Net Income Forecast for 2023 - 2025 - 2030

In the last two years, Baxter International's Net Income has grown by 28.27%, rising from $1.00B to $1.28B. For next year, analysts predict Net Income of $2.47B, which would mean an increase of 92.46%. Over the next eight years, experts predict that Baxter International's Net Income will grow at a rate of 143.03%.

2023 NI Forecast
$2.47B
2024 NI Forecast
$2.81B
2025 NI Forecast
$3.09B
2026 NI Forecast
$3.34B
2027 NI Forecast
$3.02B
2028 NI Forecast
$2.96B
2029 NI Forecast
$3.01B
2030 NI Forecast
$3.12B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
AME Stock Forecast AMETEK Inc Outperform 17
$146.38 $153.41 4.52%
RMD Stock Forecast ResMed Outperform 17
$224.60 $251.67 12.42%
HOLX Stock Forecast Hologic Inc Outperform 8
$84.68 $79.86 -2.57%

Baxter International EBITDA Forecast for 2023 - 2025 - 2030

Baxter International's EBITDA has grown In the last two years, rising from $2.61B to $2.98B – a growth of 14.39%. In the next year, analysts believe that EBITDA will reach $4.16B – an increase of 39.69%. For the next eight years, experts predict that Baxter International's EBITDA will grow at a rate of 60.47%.

2023 EBITDA Forecast
$4.16B
2024 EBITDA Forecast
$4.34B
2025 EBITDA Forecast
$4.68B
2026 EBITDA Forecast
$5.06B
2027 EBITDA Forecast
$4.74B
2028 EBITDA Forecast
$4.62B
2029 EBITDA Forecast
$4.65B
2030 EBITDA Forecast
$4.78B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
FRE Stock Forecast Fresenius SE & Co. KGaA Outperform 18
27.11€ 35.72€ 19.88%
PKI Stock Forecast PerkinElmer Outperform 16
$138.56 $159.83 17.28%
PHIA Stock Forecast Koninklijke Philips N.V. Outperform 18
15.33€ 50.07€ 98.96%

Baxter International EBIT Forecast for 2023 - 2025 - 2030

Baxter International's EBIT has seen impressive growth In the last two years, rising from $1.82B to $2.09B – a growth of 14.76%. In the next year, analysts believe that EBIT will reach $3.37B – an increase of 61.10%. For the next eight years, the forecast is for EBIT to grow by 94.95%.

2023 EBIT Forecast
$3.37B
2024 EBIT Forecast
$3.69B
2025 EBIT Forecast
$4.00B
2026 EBIT Forecast
$4.35B
2027 EBIT Forecast
$3.99B
2028 EBIT Forecast
$3.90B
2029 EBIT Forecast
$3.94B
2030 EBIT Forecast
$4.08B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
FME Stock Forecast Fresenius Medical Care AG & Co... Hold 18
35.61€ 42.10€ -10.14%
PEN Stock Forecast Penumbra Buy 9
$261.02 $0.00 11.10%
GRF Stock Forecast Grifols Outperform 18
13.65€ 27.25€ 55.31%

Baxter International EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last two years, Baxter International's EPS has grown from $3.31 to $3.61 – a 9.06% increase. Next year, analysts are expecting EPS to reach $4.87 – an increase of 34.90%. Over the next eight years, the forecast is for EPS to grow by 69.86%.

2023 EPS Forecast
$4.87
2024 EPS Forecast
$5.50
2025 EPS Forecast
$6.06
2026 EPS Forecast
$6.57
2027 EPS Forecast
$5.95
2028 EPS Forecast
$5.82
2029 EPS Forecast
$5.91
2030 EPS Forecast
$6.13
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
DVA Stock Forecast DaVita Inc Hold 16
$85.48 $81.79 -8.17%
GMED Stock Forecast Globus Medical Outperform 16
$79.63 $73.08 -3.93%
002007 Stock Forecast Hualan Biological Engineering Outperform 18
¥23.20 ¥42.59 12.07%